Germany


  • 21-October-2008

    English, , 771kb

    Pharmaceutical Pricing and Reimbursement Policies in Germany

    This paper (Health Working Paper No. 39) describes pharmaceutical pricing and reimbursement policies in Germany, considering them in the broader environment in which they operate, and assesses their impact on the achievement of a number of policy goals.

    Related Documents
  • 31-October-2006

    English

    Creation and Governance of Human Genetic Research Databases

    Summarises proceedings of a conference looking at examples of human genetic research databases, how they are established, how they are managed and governed, how they might be commercialised, and what the policy considerations might be.

  • 31-March-2006

    English

    Innovation in Pharmaceutical Biotechnology: Comparing National Innovation Systems at the Sectoral Level

    This publication examines the innovation system in pharmaceutical biotechnology in eight OECD countries. Based on rich evidence, it draws policy recommendations to foster innovation in biopharmaceuticals advocating an integrated policy approach.

  • 19-June-2001

    English

    Regulatory Developments in Xenotransplantation in Germany

    Regulatory Developments in Xenotransplantation in Germany.

    Related Documents
  • << < 1 | 2